The report focuses on the 23-Valent Pneumococcal Polysaccharide Vaccine market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the 23-Valent Pneumococcal Polysaccharide Vaccine market.
Major Players in the 23-Valent Pneumococcal Polysaccharide Vaccine market are:
Biogen Inc.
Sanofi S.A.
Pfizer Inc.
AstraZeneca
Serum Institute of India
Baxter International Inc.
GlaxoSmithKline Plc
Beijing Minhai Biotechnology
Merck & Co.
Eli Lilly and Company
On the basis of types, the 23-Valent Pneumococcal Polysaccharide Vaccine market is primarily split into:
Single Dose Vial
Pre-filled Syringe
On the basis of applications, the market covers:
For Children (2-10)
For Person (10-64)
For The old (?65)
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine Market
1.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment by Application
1.3.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of 23-Valent Pneumococcal Polysaccharide Vaccine (2017-2029)
1.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue Status and Outlook (2017-2029)
1.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the 23-Valent Pneumococcal Polysaccharide Vaccine Industry
1.7 Impact of Carbon Neutrality on the 23-Valent Pneumococcal Polysaccharide Vaccine Industry
2 23-Valent Pneumococcal Polysaccharide Vaccine Market Upstream and Downstream Analysis
2.1 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of 23-Valent Pneumococcal Polysaccharide Vaccine Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Biogen Inc.
3.1.1 Biogen Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Sanofi S.A.
3.2.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Pfizer Inc.
3.3.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.3.4 Business Overview
3.4 AstraZeneca
3.4.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Serum Institute of India
3.5.1 Serum Institute of India Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Baxter International Inc.
3.6.1 Baxter International Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.6.4 Business Overview
3.7 GlaxoSmithKline Plc
3.7.1 GlaxoSmithKline Plc Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Beijing Minhai Biotechnology
3.8.1 Beijing Minhai Biotechnology Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Merck & Co.
3.9.1 Merck & Co. Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Eli Lilly and Company
3.10.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.10.4 Business Overview
4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Landscape by Player
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Share by Player (2017-2022)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Player (2017-2022)
4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Player (2017-2022)
4.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Gross Margin by Player (2017-2022)
4.5 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
4.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
4.5.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price Trend by Type
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2017-2022)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2017-2022)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2017-2022)
5.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate of Single Dose Vial (2017-2022)
5.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate of Pre-filled Syringe (2017-2022)
6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis by Application
6.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Market Share by Application (2017-2022)
6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate of For Children (2-10) (2017-2022)
6.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate of For Person (10-64) (2017-2022)
6.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate of For The old (?65) (2017-2022)
7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Region Wise (2017-2022)
7.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share, Region Wise (2017-2022)
7.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share, Region Wise (2017-2022)
7.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2022-2029)
8.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue Forecast (2022-2029)
8.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price and Trend Forecast (2022-2029)
8.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.4 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.5 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate of Single Dose Vial (2022-2029)
8.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate of Pre-filled Syringe (2022-2029)
8.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Application (2022-2029)
8.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value and Growth Rate of For Children (2-10) (2022-2029)
8.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value and Growth Rate of For Person (10-64) (2022-2029)
8.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value and Growth Rate of For The old (?65) (2022-2029)
8.5 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast Under COVID-19
9 Industry Outlook
9.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers Analysis
9.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints and Challenges
9.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 23-Valent Pneumococcal Polysaccharide Vaccine Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 23-Valent Pneumococcal Polysaccharide Vaccine Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on 23-Valent Pneumococcal Polysaccharide Vaccine Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Encephalitis Vaccination Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 102
According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period.
The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 123
Market Overview of Global Avian Influenza Vaccines market:
According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period.
The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
Global Avian Influenza Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 155
According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period.
The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Encephalitis Vaccination market:
According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
Global Influenza Vaccine Market Research Report 2023
Published: 28-Dec-2023 Price: US 2900 Onwards Pages: 96
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- BCHT
- Jiangsu G......
Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 117
Market Overview of Global Japanese Encephalitis Vaccine market:
According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 14-Dec-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Influenza Vaccine market:
According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses...
......
2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
Published: 11-Dec-2023 Price: US 2500 Onwards Pages: 107
This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Influenza Vaccine from......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
